The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study

Background and purpose: Venous thromboembolism (VTE) is a cause of increased morbidity and risk of death. Studies report VTE in up to 30% of glioma patients but the results vary. The VTE risk is relevant when evaluating prophylaxis to avoid unnecessary bleeding or overdiagnosis. This study examines...

Full description

Saved in:
Bibliographic Details
Main Authors: Frederik R. Hovman, Frantz R. Poulsen, Steinbjørn Hansen, Rikke H. Dahlrot
Format: Article
Language:English
Published: Medical Journals Sweden 2024-11-01
Series:Acta Oncologica
Subjects:
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/40137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849221326463565824
author Frederik R. Hovman
Frantz R. Poulsen
Steinbjørn Hansen
Rikke H. Dahlrot
author_facet Frederik R. Hovman
Frantz R. Poulsen
Steinbjørn Hansen
Rikke H. Dahlrot
author_sort Frederik R. Hovman
collection DOAJ
description Background and purpose: Venous thromboembolism (VTE) is a cause of increased morbidity and risk of death. Studies report VTE in up to 30% of glioma patients but the results vary. The VTE risk is relevant when evaluating prophylaxis to avoid unnecessary bleeding or overdiagnosis. This study examines the VTE incidence in patients with glioma WHO grade 2–4, and when VTE occurred, risk factors, and overall survival (OS) for patients with WHO grade 4. Materials and methods: In total 3,630 patients with WHO grade 2 (n = 230), grade 3 (n = 317), and grade 4 (n = 3,083) gliomas from 2010 to 2018 were identified using the Danish Neuro-Oncology Registry. VTE diagnoses and time of death were obtained from Statistics Denmark. Results and interpretation: The VTE incidence was 5.2, 6.3, and 6.8% in patients with WHO grade 2, 3, and 4 gliomas, respectively. The VTE incidence rate was highest during the first 3 months after the diagnosis with 53 events. Increasing age (HR 1.03, 95%CI 1.01–1.04), male sex (HR 1.47, 95%CI 1.09–1.99), poor performance status (HR 1.57, 95%CI 1.10–2.25), and post-operative long-course radiochemotherapy (HR 2.10, 95%CI 1.19–3.72) were predictors of VTE in patients with glioma WHO grade 4. There was no difference in OS comparing patients having VTE to those without (p = 0.068). In conclusion, patients with glioma WHO grade 2–4 were at high risk of VTE, especially the first 3 months after diagnosis. Increasing age, male sex, poor performance status, and long-course radiochemotherapy were associated with increased risk of VTE in patients with glioma WHO grade 4.
format Article
id doaj-art-4efa69de921543388fda5cd0bea019d7
institution Kabale University
issn 1651-226X
language English
publishDate 2024-11-01
publisher Medical Journals Sweden
record_format Article
series Acta Oncologica
spelling doaj-art-4efa69de921543388fda5cd0bea019d72024-11-15T05:44:17ZengMedical Journals SwedenActa Oncologica1651-226X2024-11-0163110.2340/1651-226X.2024.40137The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based studyFrederik R. Hovman0https://orcid.org/0009-0002-0899-1462Frantz R. Poulsen1https://orcid.org/0000-0001-5715-6901Steinbjørn Hansen2https://orcid.org/0000-0001-5651-6493Rikke H. Dahlrot3https://orcid.org/0000-0003-1538-4361Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Neurosurgery, Odense University Hospital, Odense, Denmark; Department of Clinical Research, and BRIDGE (Brain Research – Inter Disciplinary Guided Excellence), University of Southern Denmark, Odense, DenmarkDepartment of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, DenmarkDepartment of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, DenmarkBackground and purpose: Venous thromboembolism (VTE) is a cause of increased morbidity and risk of death. Studies report VTE in up to 30% of glioma patients but the results vary. The VTE risk is relevant when evaluating prophylaxis to avoid unnecessary bleeding or overdiagnosis. This study examines the VTE incidence in patients with glioma WHO grade 2–4, and when VTE occurred, risk factors, and overall survival (OS) for patients with WHO grade 4. Materials and methods: In total 3,630 patients with WHO grade 2 (n = 230), grade 3 (n = 317), and grade 4 (n = 3,083) gliomas from 2010 to 2018 were identified using the Danish Neuro-Oncology Registry. VTE diagnoses and time of death were obtained from Statistics Denmark. Results and interpretation: The VTE incidence was 5.2, 6.3, and 6.8% in patients with WHO grade 2, 3, and 4 gliomas, respectively. The VTE incidence rate was highest during the first 3 months after the diagnosis with 53 events. Increasing age (HR 1.03, 95%CI 1.01–1.04), male sex (HR 1.47, 95%CI 1.09–1.99), poor performance status (HR 1.57, 95%CI 1.10–2.25), and post-operative long-course radiochemotherapy (HR 2.10, 95%CI 1.19–3.72) were predictors of VTE in patients with glioma WHO grade 4. There was no difference in OS comparing patients having VTE to those without (p = 0.068). In conclusion, patients with glioma WHO grade 2–4 were at high risk of VTE, especially the first 3 months after diagnosis. Increasing age, male sex, poor performance status, and long-course radiochemotherapy were associated with increased risk of VTE in patients with glioma WHO grade 4. https://medicaljournalssweden.se/actaoncologica/article/view/40137Cancer-associated thrombosisbrain tumorglioblastomaepidemiologyrisk factors
spellingShingle Frederik R. Hovman
Frantz R. Poulsen
Steinbjørn Hansen
Rikke H. Dahlrot
The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
Acta Oncologica
Cancer-associated thrombosis
brain tumor
glioblastoma
epidemiology
risk factors
title The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
title_full The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
title_fullStr The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
title_full_unstemmed The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
title_short The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study
title_sort risk of venous thromboembolism in adult patients with diffuse glioma a nationwide population based study
topic Cancer-associated thrombosis
brain tumor
glioblastoma
epidemiology
risk factors
url https://medicaljournalssweden.se/actaoncologica/article/view/40137
work_keys_str_mv AT frederikrhovman theriskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT frantzrpoulsen theriskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT steinbjørnhansen theriskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT rikkehdahlrot theriskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT frederikrhovman riskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT frantzrpoulsen riskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT steinbjørnhansen riskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy
AT rikkehdahlrot riskofvenousthromboembolisminadultpatientswithdiffusegliomaanationwidepopulationbasedstudy